Holen Sie sich die Stockscreener-App
0.76
0.64%
0.0048
Handel nachbörslich:
.76
Longeveron Inc Aktie (LGVN) Neueste Nachrichten
What’s next for Longeveron Inc. stock priceEarnings Summary Report & Risk Managed Investment Signals - Newser
Tools to monitor Longeveron Inc. recovery probabilityInflation Watch & Weekly Stock Performance Updates - Newser
Longeveron price target lowered to $3 from $10 at Roth Capital - TipRanks
Longeveron Inc. (NASDAQ:LGVN) Q2 2025 Earnings Call Transcript - Insider Monkey
Predicting Longeveron Inc. trend using moving averagesJuly 2025 Setups & Verified Technical Trade Signals - Newser
Is now a turning point for Longeveron Inc.July 2025 Gainers & Weekly Return Optimization Alerts - Newser
Backtesting results for Longeveron Inc. trading strategiesRecession Risk & AI Based Trade Execution Alerts - Newser
Longeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability - TipRanks
What’s the recovery path for long term holders of Longeveron Inc.Portfolio Performance Report & AI Based Trade Execution Alerts - Newser
Why Longeveron Inc. stock attracts strong analyst attention2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Longeveron 2025 Q2 Earnings Net Loss Widens Despite EPS Improvement - AInvest
Longeveron Plunges 11.51% on Revenue Drop - AInvest
What does recent volatility data suggest for Longeveron Inc.Quarterly Portfolio Report & Weekly High Conviction Ideas - Newser
Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Longeveron Posts 32% Revenue Drop in Q2 - AOL.com
Buy Signal for Longeveron Inc. Stock Key Technical Indicators to Watch2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
Automated trading signals detected on Longeveron Inc.July 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Longeveron Inc. Reports Q2 2025 Financial Results - TipRanks
Longeveron's Pivotal Clinical Milestones and BLA Pathway: A High-Risk, High-Reward Play in Regenerative Medicine - AInvest
Longeveron: A High-Stakes Bet on Regenerative Medicine's Future - AInvest
Longeveron's Q2 2025 Earnings: Unpacking Key Contradictions in Manufacturing, Regulatory Support, and Clinical Benchmarks - AInvest
Transcript : Longeveron Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: Longeveron sees stock surge after Q2 2025 earnings By Investing.com - Investing.com Canada
Longeveron's Stem Cell Therapy for Fatal Child Heart Condition Reaches Critical Trial Phase - Stock Titan
Longeveron Inc (LGVN) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Detecting price anomalies in Longeveron Inc. with AIJuly 2025 Outlook & Short-Term High Return Ideas - Newser
Does Longeveron Inc. outperform in volatile marketsJuly 2025 Momentum & Low Volatility Stock Recommendations - thegnnews.com
Longeveron shares rise 1.76% premarket after announcing a $17.5 million public offering. - AInvest
What does recent volatility data suggest for Longeveron Inc. [Weekly Trade Report]Free Pattern Based Trade Signal System - Newser
Regression analysis insights on Longeveron Inc. performanceQuarterly Profit Review & Target Return Focused Stock Picks - Newser
Will breakout in Longeveron Inc. lead to full recoveryLong Term Equity Screener with Safety Metrics - Newser
What makes Longeveron Inc. stock price move sharplyIntraday Price Forecast Using Volume Models - Newser
Longeveron Announces Up To $17.5 Million Public Offering - MarketScreener
Longeveron Inc. shares fall 1.01% intraday after closing a $17.5 million public offering. - AInvest
Longeveron Inc (LGVN) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Longeveron (LGVN) to Release Quarterly Earnings on Wednesday - Defense World
What MACD and RSI say about Longeveron Inc.Historical Stock Summary and ROI Review - Newser
Using economic indicators to assess Longeveron Inc. potentialChart Pattern Recognition for Profit Timing - Newser
Longeveron closes $5 million public offering of common stock By Investing.com - Investing.com Nigeria
Longeveron closes $5 million public offering of common stock - Investing.com
Longeveron Announces Closing Of Up To $17.5 Million Public Offering - The Manila Times
Longeveron Secures $17.5M Funding: Insiders Back Regenerative Medicine Breakthrough Development - Stock Titan
Technical signs of recovery in Longeveron Inc.Free Technical Entry Strategy for Beginners - Newser
Longeveron LGVN Q2 2025 Earnings Preview Upside Potential on Stem Cell Therapy Advancements - AInvest
Longeveron Inc. recovery potential after sell offReal-Time Investment Signal Forecast with AI - Newser
Chart based analysis of Longeveron Inc. trendsEntry Opportunity Screener with Confirmation - Newser
Longeveron's Capital Raise and Dilution Crisis: A Cautionary Tale for Biotech Investors - AInvest
Will Longeveron Inc. outperform tech stocksFree Portfolio Health Check - classian.co.kr
Longeveron launches offering of up to 11.8M shares via warrants and stock units - MSN
New Product Launches: Will They Boost Longeveron Inc. Stock in 2025Watchlist Generator for Smart Money Signals - Newser
Short Interest in Longeveron Inc. (NASDAQ:LGVN) Grows By 58.4% - Defense World
0.44%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):